Every Australian beauty founder Googles this eventually. Usually around the time they’ve got their formula locked, their packaging samples on the bench, and a Chinese factory quote that’s 40% cheaper than the Melbourne one sitting in the same inbox. The maths looks obvious for about ten minutes.

Then you start reading. MOQs of 20,000 units. AICIS registration. Sea freight in a 40-degree container. IP that exists only in a contract written in a jurisdiction you’ve never been to. A 16-week wait between paying your deposit and seeing a finished pallet.

I’ve run Epilab in Melbourne since 2011, and I manufacture in Australia. So take this with whatever salt that warrants. But I’ve also helped founders make the call to go overseas when it was the right call, and watched others come back after their first offshore run didn’t go the way the spreadsheet said it would. Here’s the honest version.

The case for overseas manufacturing — what it actually offers

Overseas manufacturing — primarily China (Guangdong), South Korea, Italy and Taiwan — exists at a scale Australia simply doesn’t. Guangdong alone produces more cosmetic units in a month than the entire Australian industry makes in a year. That scale buys real things:

• Lower per-unit cost — typically 20-40% cheaper at production volumes above 10,000 units per SKU, sometimes more on simple formulas.
• Vertically integrated supply chains — bottle, pump, cap, decoration and fill often happen within 20km of each other.
• Category specialisation — Korean factories have a deserved reputation for skincare innovation, Italian factories for colour cosmetics, Taiwanese for mass-market skincare.
• Faster R&D turnover at scale — some large Korean houses turn a new formula brief in 4-6 weeks because they’re doing it ten times a day.

If you’re launching a colour cosmetic line at 15,000 units per shade, or a sheet mask brand that needs 50,000 sachets to make a single retail order work, overseas isn’t a shortcut. It’s the only sensible option.

The case for Australian manufacturing

• Low MOQs. Most Australian manufacturers will run 500-3,000 units per SKU.
• AICIS compliance handled in-country. Your manufacturer knows the framework because they live inside it. (More in AICIS vs TGA.)
• Founder access. You can drive to the factory. Change the fragrance on a Tuesday and have a revised sample by Friday.
• Lead times measured in weeks, not seasons. 2-10 weeks total from brief to finished stock.
• “Australian Made” claim. Legally defensible, genuinely valued in natural, organic, baby, sensitive and post-procedure categories.
• IP under Australian law. Enforceable, accessible courts.
• Stability testing in real Australian conditions — your product was tested where it’ll live.

Where overseas wins clearly

• You’re running 10,000+ units per SKU consistently and the per-unit gap covers freight, duties and risk.
• Your category is format-heavy (sheet masks, ampoules, sachets, complex airless pumps).
• You need packaging components that aren’t made in Australia.
• You’re chasing a Korean or Italian aesthetic baked into manufacturing culture there.
• Your margin only works at imported cost.

Where Australian wins clearly

• You’re launching and don’t yet know whether your product will sell.
• Your brand story is built on local.
• You’re in a regulated or sensitive category.
• You iterate constantly.
• You value the call — being able to ring the manufacturer on Wednesday.

The cost reality (real numbers, not assumptions)

This is where most “vs” articles wave their hands. Here are the numbers I actually see, across roughly 200 founders I’ve quoted in the last few years. A 100ml moisturiser in a stock pump bottle, mid-complexity formula:

• Overseas (China, 20,000 units): roughly $2.40-$3.10 ex-factory, plus $0.35-$0.55/unit freight, plus duties
• Overseas (Korea, 10,000 units): roughly $3.20-$4.50 ex-factory, plus freight
• Australia (3,000 units): roughly $4.80-$6.50 finished and palletised
• Australia (500 units, launch run): roughly $7.00-$9.50 finished

At equivalent ex-factory prices, China is almost always cheaper than Australia. The accurate framing: at very low volumes (sub-2,000 units per SKU), Australian manufacturing often comes out roughly competitive once you factor in freight, duties, the AICIS work you still need to do, and the cost of capital tied up in inventory you can’t move. Above 10,000 units per SKU per run, overseas wins clearly on per-unit cost. The Australian advantage isn’t usually price — it’s everything else.

The full launch maths sits in Skincare brand launch cost in Australia.

The verification problem — what’s actually in your product?

This is the part of overseas manufacturing nobody talks about. You can take a Chinese factory’s COA (certificate of analysis) at face value, and most founders do. The question that should keep founders up at night is: how would you know if they swapped an ingredient on you?

Three patterns I’ve seen in the field:

Sample-to-production substitution. What you tested as a stable, beautiful sample isn’t always what comes off the production line. A factory makes 500 samples to your spec, then at production scale substitutes a cheaper version of a premium active — often something close enough that the formula still functions, but with a different performance profile. You launch, customer reviews start hinting at “it doesn’t feel like it used to,” and by the time you’ve isolated the cause you’ve shipped 8,000 units of something you didn’t sign off on.

Ingredient-grade swaps mid-batch. Premium versions of a single ingredient — pharmaceutical-grade hyaluronic acid versus cosmetic-grade, encapsulated retinol versus non-encapsulated, low-irritation niacinamide versus standard — can vary by 5-20x in cost while the INCI name on the label stays identical. You’ll never see the difference on a COA unless you specifically test for it.

The “second factory” problem. Some overseas operations subcontract overflow runs to other facilities you’ve never audited. Your stable formula made on Line A might be made on Line B for the 25,000-unit run that has to ship before Chinese New Year. The COA you receive is for the sample, not the batch.

How you actually verify (vs. how most founders think they verify): Most founders assume a COA from the factory is verification. It’s not. A COA confirms the factory’s own test of their own batch — it’s a trust signal, not an independent check. Real verification requires an independent third-party lab test on a retained sample from each production batch ($400-$800 per batch, run by a lab you appoint), a spec sheet that names exact ingredient grades not just INCI names, contract clauses that allow batch rejection on independent test failure, and holding 5-10% of each shipment for retention testing for at least 24 months. Most boutique founders skip it.

Holding an overseas factory accountable. If something does go wrong, your legal recourse depends on the jurisdiction in your manufacturing agreement, whether you have proof of substitution, and whether the factory still exists and has assets when you go after them. The realistic timeline for international commercial dispute resolution is 18-36 months and the realistic enforcement rate is well under 50%. The cost to litigate from Australia is typically $50,000-$200,000+ before you’ve recovered a dollar. Compare with manufacturing in Australia, where a failed-batch conversation happens face-to-face within 48 hours, where the manufacturer has assets and reputation on the line in your local market, and where the legal pathway (if it ever came to that) is the same as suing your accountant.

The regulatory reality (AICIS, TGA, ingredient compliance)

If you import finished cosmetic product into Australia, you are the introducer under AICIS. The factory in Guangdong is not. You are responsible for ingredient inventory listings, categorisation, annual declarations, and any reporting obligations triggered by your formula.

Roughly one in four overseas formulas we see contains at least one ingredient that’s either not listed on AICIS, listed under a different CAS number than the manufacturer claims, or subject to a concentration limit the formulator didn’t know about. That’s a fixable problem if you find it before you import 20,000 units. It’s a very expensive problem if you find it after.

If you manufacture in Australia, your manufacturer is doing this work as a condition of accepting the brief. If your product crosses into therapeutic territory (sunscreen above SPF 15, anti-acne claims), TGA applies regardless of where it’s made — but coordinating TGA submissions across a 7,000km supply chain is its own form of suffering. Full breakdown in AICIS vs TGA.

The supply chain reality

Lead times. Overseas: 4-12 weeks production, 4-8 weeks sea freight, 1-2 weeks customs. Call it 12-22 weeks from PO to warehouse. Australia: 2-10 weeks total.

Shipping risk. A 40-foot container crossing the equator hits temperatures well above 40°C for sustained periods. Emulsions can separate. Fragrances can shift. Pump mechanisms can deform. Marine insurance covers the loss; it doesn’t cover the launch you missed.

IP risk. Chinese IP law has improved meaningfully over the last decade. It is no longer accurate to say “your formula will be copied.” It is accurate to say enforcement is harder, slower and more expensive from Australia. NDAs are signed. NDAs are also, sometimes, ignored.

The hybrid path some founders take

• Australian R&D, overseas production. Brand develops in Australia, transfers spec offshore once proven.
• Core line local, accessories imported. Hero products made in Australia where the story matters.
• Launch local, scale offshore. Run 1,000-5,000 units in Australia to prove the SKU, move offshore once you’re consistently moving 10,000+ per quarter. Most common successful pattern we see.
• Local for the regulated stuff, offshore for the rest.

How to know which is right for you

1. What’s your committed volume per SKU per year? Under 5,000: Australia. 5,000-15,000: real decision. Over 15,000: overseas math gets compelling.
2. How settled is your formula? Still iterating: Australia. Locked and proven: either works.
3. Does your brand story rely on local manufacture? Yes: Australia. No: open question.
4. What’s your regulatory profile? TGA-adjacent, baby, sensitive, post-procedure: Australia. Standard cosmetic: either.
5. How much working capital can you tie up in inventory on water for 6-10 weeks? Not much: Australia.

If you want a structured way to vet whichever direction you choose, work through our choosing a cosmetic contract manufacturer checklist. And if you’re still mapping the whole launch, the complete guide to launching a skincare brand in Australia is the place to start.

Epilab’s positioning, plainly: Melbourne contract manufacturer, GMP-aligned, MOQs from around 500 units, founder-led. Not the right call if you need 50,000 units of sheet masks. A good call if you’re launching, iterating, or running a boutique-through-retail-scale brand and you want to keep the manufacture inside a phone call.

Frequently asked questions

Is it always cheaper to manufacture cosmetics overseas?

At equivalent ex-factory prices and high volumes (10,000+), overseas is typically 20-40% cheaper. At low volumes (500-3,000 units per SKU), Australian manufacturing often comes out roughly competitive once you factor in freight, duties, the AICIS work you still need to do, and the cost of capital tied up in inventory you can’t move.

Can I sell my product as “Australian Made” if I manufacture overseas?

No. The Australian Made claim requires substantial transformation in Australia and a meaningful proportion of production cost incurred here. Filling, mixing or labelling alone usually doesn’t qualify.

What regulatory obligations apply if I manufacture overseas and import?

You become the introducer under AICIS and carry full responsibility for ingredient compliance, categorisation, annual declarations and reporting. If your product makes therapeutic claims, TGA obligations apply on top.

How do I verify what’s actually in my overseas-manufactured product?

A factory’s COA confirms the factory’s own test of their own batch — it’s a trust signal, not an independent check. Real verification requires independent third-party lab tests on retained samples from each batch, ingredient-grade-specific spec sheets, contract clauses for rejection on test failure, and retention samples held 24+ months. Most boutique founders skip it.

What’s a typical lead time for overseas vs Australian cosmetic manufacturing?

Overseas: 12-22 weeks from PO to Australian warehouse. Australia: 2-10 weeks total.

When does Australian manufacturing make sense over overseas?

At launch and through boutique scale (under ~10,000 units per SKU per run), when your brand story relies on local manufacture, when you’re in a regulated or sensitive category, when you’re still iterating on formula, or when keeping the manufacture inside a short drive matters more than squeezing the per-unit cost.

Launching as an indie or small brand? See our dedicated page for cosmetic contract manufacturing for indie and small beauty brands — covering 500-unit MOQs, realistic launch budgets, and the growth path from pilot to retail scale.

Serving brands across Australia

Manufacturing happens at our Melbourne facility, but most of the brands we work with are based interstate. For full national context see our Cosmetic Contract Manufacturer Australia page, or state-specific detail at Sydney, Brisbane, or Perth.